Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Vanguard Health Care ETF (VHT) and Invesco Dynamic Pharmaceuticals ETF (PJP) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. VHT is less expensive with a Total Expense Ratio (TER) of 0.09%, versus 0.57% for PJP. VHT is down -1.75% year-to-date (YTD) with -$151M in YTD flows. PJP performs better with 0.96% YTD performance, and +$89M in YTD flows. Run a side-by-side ETF comparison of VHT and PJP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | VHT PJP | -2.15%-3.66% | -1.03%+0.35% | -1.75%+0.96% | +8.26%+25.49% | +28.41%+46.89% | +33.99%+39.70% |
| Flows | VHT PJP | -$68M+$6M | -$266M+$93M | -$151M+$89M | -$706M+$91M | -$2.52B+$6M | -$233M-$49M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | VHT PJP | +13.05%+14.70% | +17.31%+18.60% | +13.62%+15.30% | +14.96%+15.87% |
| Max drawdown | VHT PJP | -5.00%-5.17% | -11.85%-13.71% | -16.88%-16.11% | -17.77%-17.41% |
| Max drawdown duration | VHT PJP | 63d31d | 190d130d | 435d275d | 767d788d |
VHT | PJP | |
Last sale 3/12/2026 at 1:30 PM | $277.21 | $102.80 |
| Previous close 03/11/2026 | $282.75 | $105.46 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
VHT | PJP | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
VHT | PJP | |
|---|---|---|
| Last price | $277.21 | $102.80 |
| 1D performance | -1.96% | -2.52% |
| AuM | $16.88 B | $406.31 M |
| E/R | 0.09% | 0.57% |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
